KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Oaktree Specialty Lending (OCSL) Other Non Operating Income (2021 - 2026)

Oaktree Specialty Lending's Other Non Operating Income history spans 5 years, with the latest figure at $1.2 million for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 88.43% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a 88.24% decrease, with the full-year FY2025 number at -$11.1 million, down 1067.37% from a year prior.
  • Other Non Operating Income hit $1.2 million in Q4 2025 for Oaktree Specialty Lending, up from -$8.8 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for OCSL hit a ceiling of $10.5 million in Q4 2024 and a floor of -$11.0 million in Q4 2022.
  • Historically, Other Non Operating Income has averaged $880444.4 across 5 years, with a median of $1.7 million in 2022.
  • Biggest five-year swings in Other Non Operating Income: crashed 470.15% in 2022 and later soared 2328.97% in 2024.
  • Tracing OCSL's Other Non Operating Income over 5 years: stood at $3.0 million in 2021, then crashed by 470.15% to -$11.0 million in 2022, then increased by 28.88% to -$7.8 million in 2023, then soared by 234.13% to $10.5 million in 2024, then crashed by 88.43% to $1.2 million in 2025.
  • Business Quant data shows Other Non Operating Income for OCSL at $1.2 million in Q4 2025, -$8.8 million in Q3 2025, and $1.9 million in Q2 2025.